XSHG
600873
Market cap3.36bUSD
Jul 10, Last price
8.06CNY
1D
-0.86%
1Q
-26.93%
Jan 2017
23.62%
Name
MeiHua Holdings Group Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MeiHua Holdings Group Co.,Ltd, a company established in Langfang, China, in 2002, specializes in delivering comprehensive amino acid-based nutrition and health solutions. Its diverse product portfolio caters to multiple industries. For the food sector, MeiHua manufactures an array of additives such as sodium glutamate, natamycin, disodium 5'-ribonucleotide, disodium inosinate, xanthan gum, pullulan, and trehalose. It also produces essential condiments like monosodium glutamate (MSG). The company provides various amino acids designed for animal feed, including valine, L-lysine sulphate and HCL, L-threonine, and L-tryptophane. Additionally, its feedstuff offerings comprise corn gluten meal, corn husk powder, corn fiber feed, and specialized MSG residue. In the pharmaceutical domain, MeiHua supplies vital amino acids such as L-glutamine, L-leucine, L-isoleucine, L-valine, branched-chain amino acids (BCAA), L-proline, inosine, vernine, and adenosine. Beyond these core areas, MeiHua's extensive product line also encompasses colloids, a variety of capsules (enteric, cellulose, gelatin, and pullulan types), and agricultural fertilizers, particularly soil conditioners.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||